If you're an adult without heart disease and you get 150 to 300 minutes of brisk exercise each week, you're less likely to die from any cause — especially if your body has trouble processing sugar. This amount of activity might help reduce the danger that comes with metabolic issues.
See the scientific wording
Among adults without prevalent cardiovascular disease, engaging in 150–299 minutes per week of moderate-to-vigorous physical activity (MVPA) is associated with a 15% lower risk of all-cause mortality compared to less than 150 minutes per week, particularly among those with moderate insulin resistance (TyG-WHtR index 7.01–8.03), suggesting this level of activity may mitigate mortality risk linked to metabolic dysfunction.
Correlational — new studies may shift this
ObservationalOne moderate-quality study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Cohort StudyHuman2025
This study found that adults who exercise 150–300 minutes a week — even if they have some insulin resistance — are 11% less likely to die early than those who exercise less, and this benefit is strongest in people with moderate metabolic issues.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
If you're an adult without heart disease and you get 150 to 300 minutes of brisk exercise each week, you're less likely to die from any cause — especially if your body has trouble processing sugar. This amount of activity might help reduce the danger that comes with metabolic issues.
Evidence from Studies
Supporting (1)
Community contributions welcome
This study found that adults who exercise 150–300 minutes a week — even if they have some insulin resistance — are 11% less likely to die early than those who exercise less, and this benefit is strongest in people with moderate metabolic issues.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review & Meta-Analysis of MVPA (150–299 min/week) and All-Cause Mortality in Adults Without Cardiovascular Disease, Stratified by TyG-WHtR Index
Systematic review and meta-analysis of prospective cohort studies evaluating MVPA exposure (150–299 min/week vs. <150 min/week) and all-cause mortality in adults without prevalent CVD, with stratification by TyG-WHtR index and adjustment for confounders.
Randomized Controlled Trial of 150–299 min/week MVPA vs. <150 min/week on All-Cause Mortality in Adults Without CVD and Moderate Insulin Resistance
Randomized controlled trial assigning adults without CVD and TyG-WHtR index 7.01–8.03 to either 150–299 min/week MVPA or <150 min/week control, with long-term follow-up for all-cause mortality as primary outcome.
Prospective Cohort Study of MVPA and All-Cause Mortality in Adults Without CVD by TyG-WHtR Strata
Prospective cohort study following adults without CVD over 5–10 years, measuring MVPA via accelerometry and TyG-WHtR at baseline, and tracking all-cause mortality with adjustment for confounders.
Case-Control Study Comparing MVPA Exposure in Adults Who Died vs. Survived, Stratified by TyG-WHtR Index
Case-control study comparing past MVPA exposure (150–299 min/week vs. <150 min/week) in adults without CVD who died from any cause versus matched survivors, with TyG-WHtR measured retrospectively.
Cross-Sectional Analysis of MVPA, TyG-WHtR, and Mortality Risk in Adults Without CVD
Cross-sectional survey measuring MVPA, TyG-WHtR index, and self-reported mortality risk or survival status in a population of adults without CVD at one point in time.